v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
At The Market Offering With Maxim
Vivasor investment
Issuance of common stock in connection with May Offering
February 2025 Offering
Common Shares
Common Shares
At The Market Offering With Maxim
Common Shares
Vivasor investment
Common Shares
Issuance of common stock in connection with May Offering
Common Shares
February 2025 Offering
Additional Paid-in Capital
Additional Paid-in Capital
At The Market Offering With Maxim
Additional Paid-in Capital
Vivasor investment
Additional Paid-in Capital
Issuance of common stock in connection with May Offering
Additional Paid-in Capital
February 2025 Offering
Accumulated Deficit
Beginning Balance (in shares) at Dec. 31, 2024           52,034,060                    
Beginning Balance at Dec. 31, 2024 $ 85,726         $ 5         $ 384,172         $ (298,451)
Equity                                
Stock-based compensation (in shares)           5,986,893                    
Stock-based compensation 648                   648          
Issuance of common stock, net of fees (in shares)                   4,757,126            
Issuance of common stock, net of fees         $ 4,860         $ 1         $ 4,859  
Issuance of common stock in connection with warrant exercise (in shares)           3,246,111                    
Conversion of liability warrants to equity warrants 15                   15          
Net loss (9,563)                             (9,563)
Ending Balance (in shares) at Mar. 31, 2025           66,024,190                    
Ending Balance at Mar. 31, 2025 81,686         $ 6         389,694         (308,014)
Beginning Balance (in shares) at Dec. 31, 2024           52,034,060                    
Beginning Balance at Dec. 31, 2024 85,726         $ 5         384,172         (298,451)
Equity                                
Net loss (46,679)                              
Ending Balance (in shares) at Jun. 30, 2025           86,661,219                    
Ending Balance at Jun. 30, 2025 74,069         $ 7         419,192         (345,130)
Beginning Balance (in shares) at Mar. 31, 2025           66,024,190                    
Beginning Balance at Mar. 31, 2025 81,686         $ 6         389,694         (308,014)
Equity                                
Stock-based compensation (in shares)           3,701,197                    
Stock-based compensation 1,151                   1,151          
Equity issuance costs (137)                   (137)          
Issuance of common stock with NYIAX transaction (in shares)           1,500,000                    
Issuance of common stock in connection with warrant exercise (in shares)           2,989,887                    
Issuance of common stock for conversions (in shares)           1,845,945                    
Issuance of common stock for conversions 1,545                   1,545          
Issuance of warrants with the 2025 Notes 16,657                   16,657          
Issuance of common stock for the acquisition of CompuSystems, Inc. (in shares)           10,600,000                    
Issuance of common stock for the acquisition of CompuSystems, Inc. 10,283         $ 1         10,282          
Net loss (37,116)                             (37,116)
Ending Balance (in shares) at Jun. 30, 2025           86,661,219                    
Ending Balance at Jun. 30, 2025 74,069         $ 7         419,192         (345,130)
Beginning Balance (in shares) at Dec. 31, 2025           573,438,153                    
Beginning Balance at Dec. 31, 2025 237,974         $ 59         615,360         (377,445)
Equity                                
Stock-based compensation (in shares)           211,131                    
Stock-based compensation 5,234                   5,234          
Equity issuance costs (250)                   (250)          
Issuance of common stock for intangible assets acquisition (in shares)           7,500,000                    
Issuance of common stock for intangible asset acquisition 5,401         $ 1         5,400          
Issuance of common stock, net of fees (in shares)             36,663,892                  
Issuance of common stock, net of fees   $ 24,800         $ 3         $ 24,797        
Net loss (53,131)                             (53,131)
Ending Balance (in shares) at Mar. 31, 2026           617,813,176                    
Ending Balance at Mar. 31, 2026 220,028         $ 63         650,541         (430,576)
Beginning Balance (in shares) at Dec. 31, 2025           573,438,153                    
Beginning Balance at Dec. 31, 2025 237,974         $ 59         615,360         (377,445)
Equity                                
Issuance of common stock, net of fees (in shares)   40,179,626                            
Net loss (141,156)                              
Ending Balance (in shares) at Jun. 30, 2026           854,456,625                    
Ending Balance at Jun. 30, 2026 245,894         $ 87         764,408         (518,601)
Beginning Balance (in shares) at Mar. 31, 2026           617,813,176                    
Beginning Balance at Mar. 31, 2026 220,028         $ 63         650,541         (430,576)
Equity                                
Stock-based compensation (in shares)           46,094,139                    
Stock-based compensation 5,657                   5,657          
Equity issuance costs (2,108)                   (2,108)          
Issuance of common stock with NYIAX transaction (in shares)           2,000,000                    
Issuance of common stock, net of fees (in shares)             3,515,734 75,942,666 109,090,910              
Issuance of common stock, net of fees   $ 2,376 $ 56,198 $ 55,740     $ 5 $ 8 $ 11     $ 2,371 $ 56,190 $ 55,729    
Warrant dividend classified as liability (3,972)                   (3,972)          
Net loss (88,025)                             (88,025)
Ending Balance (in shares) at Jun. 30, 2026           854,456,625                    
Ending Balance at Jun. 30, 2026 $ 245,894         $ 87         $ 764,408         $ (518,601)